Press Releases

Ambience Healthcare and St. Luke's Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

Ambience Healthcare, the leading AI platform for healthcare documentation, scribing, coding, CDI, and patient summaries, announced today a pilot study with St. Luke's Health System has resulted in a 25% reduction in clinician burnout and a nearly 23% increase in patient face time for clinicians.

Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its integration with Aura, the specialty diagnostics suite from leading electronic health record (EHR) company Epic. This integration will give organizations using Epic the ability to order Baylor Genetics’ tests and view results directly in the EHR—supporting fast, informed treatment decisions and improving the provider experience. Baylor Genetics will be the first lab to offer WGS testing through Aura.

Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology

Record year comes as the rise of precision medicine drives a surge in demand

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics

STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance

STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.

Coronado Research announce appointment of Jo Marshall as EVP Data Services and Advanced Analytics

Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Leica Biosystems and Indica Labs today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs.

PrecisionLife Appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare

PrecisionLife announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare.

ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study

ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.

Vergent Bioscience Receives FDA Fast Track Designation for Abenacianine for Injection (VGT-309) to Help Surgeons Visualize Tumors in the Lung During Surgery

Vergent Bioscience announced that the U.S. Food & Drug Administration has granted Fast Track designation for the company’s novel, investigational tumor-targeted fluorescent imaging agent, abenacianine for injection (VGT-309), as an adjunct for the intraoperative visualization of primary lung cancer, other pulmonary lesions, cancer containing lymph nodes, and positive surgical margins in patients undergoing surgery for known or suspected cancer in the lung.

ClearNote Health’s Avantect® Test Selected for World’s Largest Study of Pancreatic Cancer Detection in High-Risk Patient Population

ClearNote Health's Avantect Pancreatic Cancer test was selected for a large UK NHS study that will include up to 15,000 patient participants recently diagnosed with type 2 diabetes. The Avantect test is a blood-based assay designed to use key epigenomic and genomic signals to detect the earliest indicators of pancreatic cancer.

electronRx to Launch purpleDx Pulmonary Disease Smartphone App for Remote Lung Function Monitoring

*Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve therapeutic outcomes for chronic respiratory disease patients *electronRx to showcase purpleDx at CES 2025 (7–10 Jan, Las Vegas)

Coronado Research announce appointment of Dr Jennifer Bradford as VP, Head of Data Science

Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.

The Institute of Tissue Medicine of the University of Bern Chooses Indica Labs’ HALO AP® to Become the First Public Health Institute in Switzerland to Deploy Digital Pathology for Diagnostics in the Cloud with Amazon Web Services (AWS)

Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.

PathAI Launches AIM-IHC Breast Panel on AISight® Platform to Streamline Breast Cancer Biomarker Quantification and Improve Pathologist Efficiency

PathAI, a leader in AI-powered pathology solutions, today announced the launch of the AIM-IHC Breast Panel, a set pf advanced AI-assisted, algorithms designed to quantify critical breast cancer biomarkers—HER2, ER, PR, and Ki-67.

Phastar Scoops Prestigious 2024 Scrip Award

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.

Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours

Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.

Huateng Pharma Provides PEG-Based Hydrogels for Medical Device Applications

Clinion Wins 2024 SCDM Innovation Award for Excellence in Clinical Data Science

Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.